OC
VERO

Oppenheimer & Co’s Venus Concept VERO Stock Holding History

Oppenheimer & Co’s Portfolio VERO Stock Details VERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-94
Closed -$48K – 1577
2021
Q2 		$48K Buy
+94
New +$33.9K ﹤0.01% 1487

Other funds holding VERO

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Oppenheimer & Co's VERO Position: Q3 2021 in Review

Oppenheimer & Co sold out of Venus Concept (VERO) in Q3 2021, closing a stake of 94 shares — an estimated $48K sold.

Oppenheimer & Co first reported a position in VERO in Q2 2021 and held it in 1 quarter. The position peaked at $48K in Q2 2021. 42 funds tracked by Wall St. Rank hold VERO as of Q3 2021.

  • Oppenheimer & Co reported no remaining Venus Concept position as of Q3 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 94 Venus Concept shares in Q3 2021, an estimated $48K.
  • Oppenheimer & Co first reported a position in Venus Concept in Q2 2021 and held it in 1 quarter.
  • Oppenheimer & Co's Venus Concept position peaked at $48K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Venus Concept as of Q3 2021.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.